0001600132-20-000104.txt : 20200914
0001600132-20-000104.hdr.sgml : 20200914
20200914160401
ACCESSION NUMBER: 0001600132-20-000104
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20200910
FILED AS OF DATE: 20200914
DATE AS OF CHANGE: 20200914
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Wang Theodore T
CENTRAL INDEX KEY: 0001694061
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-36845
FILM NUMBER: 201173218
MAIL ADDRESS:
STREET 1: C/O PUISSANCE CAPITAL MANAGEMENT LP
STREET 2: 950 THIRD AVENUE, 25TH FLOOR
CITY: NEW YORK
STATE: NY
ZIP: 10022
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Bellerophon Therapeutics, Inc.
CENTRAL INDEX KEY: 0001600132
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 473116175
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 184 LIBERTY CORNER ROAD, SUITE 302
CITY: WARREN
STATE: NJ
ZIP: 07059
BUSINESS PHONE: 908-574-4770
MAIL ADDRESS:
STREET 1: 184 LIBERTY CORNER ROAD, SUITE 302
CITY: WARREN
STATE: NJ
ZIP: 07059
FORMER COMPANY:
FORMER CONFORMED NAME: Bellerophon Therapeutics LLC
DATE OF NAME CHANGE: 20140213
4
1
wf-form4_160011382783695.xml
FORM 4
X0306
4
2020-09-10
0
0001600132
Bellerophon Therapeutics, Inc.
BLPH
0001694061
Wang Theodore T
C/O PUISSANCE CAPITAL MANAGEMENT LP
950 THIRD AVENUE, 25TH FLOOR
NEW YORK
NY
10022
1
0
1
0
Stock Option (right to buy)
10.12
2020-09-10
4
A
0
6509
10.12
A
2021-09-10
2030-09-10
Common Stock
6509.0
13806
D
/s/ Theodore T. Wang
2020-09-14